Is CLSZF or JNJ a better dividend investment in 2026?

CLSZF currently yields 15873.02% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: CLSZF offers higher current income.

What is the dividend yield difference between CLSZF and JNJ?

CLSZF has a forward dividend yield of 15873.02% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 15870.89 percentage points.

Home › Compare › CLSZF vs JNJ

CLSZF vs JNJ: Dividend Comparison 2026

CLSZF yields 15873.02% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLSZF wins by $5303702155141833728.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLSZF

● Live price

15873.02%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5303702155141833728.00M

Annual income

$5,238,777,702,532,955,000,000,000.00

Full CLSZF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — CLSZF vs JNJ

📍 CLSZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLSZF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLSZF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLSZF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSZF

Annual income on $10K today (after 15% tax)

$1,349,206.35/yr

After 10yr DRIP, annual income (after tax)

$4,452,961,047,153,011,600,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, CLSZF beats the other by $4,452,961,047,153,011,600,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSZF + JNJ for your $10,000?

CLSZF: 50%JNJ: 50%

100% JNJ50/50100% CLSZF

Portfolio after 10yr

$2651851077570916864.00M

Annual income

$2,619,388,851,266,477,400,000,000.00/yr

Blended yield

98.78%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLSZF

No analyst data

Altman Z

1.4

Piotroski

6/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSZF buys

JNJ buys

No recent congressional trades found for CLSZF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLSZFJNJ

Forward yield	15873.02% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$5303702155141833728.00M ✓	$30.3K
Annual income after 10y	$5,238,777,702,532,955,000,000,000.00 ✓	$4,689.40
Total dividends collected	$5299408852070916096.00M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CLSZF vs JNJ ($10,000, DRIP)

Year	CLSZF Portfolio	CLSZF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$1,598,002	$1,587,301.59	$10,592	$272.30	+$1.59M → CLSZF
2	$238,766,914	$237,057,051.97	$11,289	$357.73	+$238.76M → CLSZF
3	$33,358,380,506	$33,102,899,908.67	$12,123	$472.89	+$33358.37M → CLSZF
4	$4,357,975,242,348	$4,322,281,775,206.41	$13,141	$629.86	+$4357975.23M → CLSZF
5	$532,389,771,066,305	$527,726,737,556,992.20	$14,408	$846.81	+$532389771.05M → CLSZF
6	$60,821,490,208,810,690	$60,251,833,153,769,736.00	$16,021	$1,151.60	+$60821490208.79M → CLSZF
7	$6,498,083,286,836,623,000	$6,433,004,292,313,197,000.00	$18,122	$1,588.22	+$6498083286836.60M → CLSZF
8	$649,283,058,580,737,600,000	$642,330,109,463,822,300,000.00	$20,930	$2,228.20	+$649283058580737.63M → CLSZF
9	$60,677,058,512,970,960,000,000	$59,982,325,640,289,564,000,000.00	$24,792	$3,191.91	+$60677058512970960.00M → CLSZF
10	$5,303,702,155,141,834,000,000,000	$5,238,777,702,532,955,000,000,000.00	$30,274	$4,689.40	+$5303702155141833728.00M → CLSZF

CLSZF vs JNJ: Complete Analysis 2026

CLSZF — Stock

China Oil And Gas Group Limited, an investment holding company, primarily invests in natural gas and energy related businesses in the People's Republic of China and Canada. The company operates through four segments: Sales and Distribution of Natural Gas and Other Related Products; Gas Pipeline Construction and Connection; Exploitation and Production of Crude Oil and Natural Gas; and Production and Sales of Coal Gasification and Other Related Products. It is involved in the piped city gas business, as well as design and construction of gas pipelines; and the transportation, distribution, and sale of compressed natural gas and liquefied natural gas. The company also develops, produces, and sells crude oil and natural gas, and other upstream energy resources; constructs and operates gas pipelines and natural gas stations; and provision for finance, as well as involved in the trading of natural gas and related equipment. In addition, it operates natural gas stations for automobiles. The company serves approximately 1,765,241 residential users; and 15,602 industrial and commercial users. China Oil And Gas Group Limited is headquartered in Causeway Bay, Hong Kong.

Full CLSZF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this CLSZF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSZF vs SCHD CLSZF vs JEPI CLSZF vs O CLSZF vs KO CLSZF vs MAIN CLSZF vs ABBV CLSZF vs MRK CLSZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.